Abstract:The polyketide specialized metabolites of bacteria are attractive targets for generating analogues, with the goal of improving their pharmaceutical properties. Here, we aimed to produce C-26 derivatives of the giant anti-cancer stambomycin macrolides using a mutasynthesis approach, as this position has been shown previously to directly impact bioactivity. For this, we leveraged the intrinsically broad specificity of the acyl transferase domain (AT12) of the modular polyketide synthase (PKS), which is responsible for the alkyl branching functionality at this position. Feeding of a panel of synthetic and commercially available dicarboxylic acid "mutasynthons" to an engineered strain of Streptomyces ambofaciens (Sa) deficient in synthesis of the native alpha-carboxyacyl-CoA extender units, resulted in six new series of stambomycin derivatives as judged by LC-HRMS and NMR. Notably, the highest product yields were observed for substrates which were only poorly accepted when AT12 was transplanted into a different PKS module, suggesting a critical role for domain context in the overall functioning of PKS proteins. We also demonstrate the superiority of this mutasynthesis approach - both in terms of absolute titers and yields relative to the parental compounds - in comparison to the alternative precursor-directed strategy in which monoacid building blocks are supplied to the wild type strain. We further identify a malonyl-CoA synthetase, MatB_Sa, with specificity distinct from previously identified promiscuous enzymes, making it a useful addition to a mutasynthesis toolbox for generating atypical, CoA activated extender units. Finally, we show that two of the obtained (deoxy)-butyl-stambomycins exhibit antibacterial and antiproliferative activities similar to the parental stambomycins, while an unexpected butyl-demethyl congener is less potent. Overall, this works confirms the interest of biosynthetic pathways which combine a dedicated route to extender unit synthesis and a broad specificity AT domain for producing bioactive derivatives of fully-elaborated complex polyketides.

Elucidation of first step of the allylmalonyl-CoA biosynthetic pathway by expression of heterologous KSIII gene and enhancement of 36-methyl-FK506 production by genetic and chemical engineering

Improvement of FK506 Production in Streptomyces Tsukubaensis by Genetic Enhancement of the Supply of Unusual Polyketide Extender Units Via Utilization of Two Distinct Site-Specific Recombination Systems

Genome-scale metabolic network guided engineering of Streptomyces tsukubaensis for FK506 production improvement

Enhancement of FK506 Production by Engineering Secondary Pathways of Streptomyces Tsukubaensis and Exogenous Feeding Strategies

Production Improvement of FK506 in Streptomyces Tsukubaensis by Metabolic Engineering Strategy

Balancing carbon flux rebalancing around phosphoenolpyruvate node for enhancement of FK506 production in Streptomyces tsukubaensis

FkbN and Tcs7 are pathway-specific regulators of the FK506 biosynthetic gene cluster in Streptomyces tsukubaensis L19

Elevation of FK506 Production by Regulatory Pathway Engineering and Medium Optimization in Streptomyces Tsukubaensis

Enhanced FK506 production in Streptomyces tsukubaensis by rational feeding strategies based on comparative metabolic profiling analysis.

Substrate Specificity of Acyltransferase Domains for Efficient Transfer of Acyl Groups.

Improved FK506 Production by the Precursors and Product-Tolerant Mutant of Streptomyces Tsukubaensis Based on Genome Shuffling and Dynamic Fed-Batch Strategies

Functional expression of genes involved in the biosynthesis of the novel polyketide chain extension unit, methoxymalonyl-acyl carrier protein, and engineered biosynthesis of 2-desmethyl-2-methoxy-6-deoxyerythronolide B.

Comparative proteomic and metabolomic analysis of Streptomyces tsukubaensis reveals the metabolic mechanism of FK506 overproduction by feeding soybean oil

Enhancement of FK520 Production in Streptomyces Hygroscopicus by Combining Traditional Mutagenesis with Metabolic Engineering.

Enhanced amphotericin B production by genetically engineered Streptomyces nodosus

Phage P1-Derived Artificial Chromosomes Facilitate Heterologous Expression of the FK506 Gene Cluster.

Reconstitution of the FK228 biosynthetic pathway reveals cross talk between modular polyketide synthases and fatty acid synthase

Biochemical Characterization of a Malonyl-Specific Acyltransferase Domain of FK506 Biosynthetic Polyketide Synthase

Enhanced Salinomycin Production by Adjusting the Supply of Polyketide Extender Units in Streptomyces Albus

Exploiting the inherent promiscuity of the acyl transferase of the stambomycin polyketide synthase for the mutasynthesis of analogues

Two-Component-System RspA1/A2-Dependent Regulation on Primary Metabolism in Streptomyces albus A30 Cultivated With Glutamate as the Sole Nitrogen Source